Welcome to our dedicated page for KEYCORP /NEW/ SEC filings (Ticker: KEY), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on KEYCORP /NEW/'s stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into KEYCORP /NEW/'s regulatory disclosures and financial reporting.
KEYCORP director Christopher L. Henson reported a compensation-related award of 7,352 Deferred Shares. These Deferred Shares are economically equivalent to the company’s Common Shares and were granted under KeyCorp’s Amended and Restated Directors’ Deferred Share Sub-Plan of the KeyCorp 2026 Equity Compensation Plan.
Under the plan, Henson is scheduled to receive payment of the 7,352 Deferred Shares one-half as Common Shares and one-half in cash on May 14, 2029. Following the transactions reported, he also holds 250 Common Shares directly. The filing reflects a grant/award acquisition, not an open-market purchase or sale.
Gile Elizabeth R. reported acquisition or exercise transactions in this Form 4 filing.
KEYCORP director Elizabeth R. Gile received 7,352 Deferred Shares as a compensation award. Each Deferred Share is the economic equivalent of one Common Share and was granted under KeyCorp's Amended and Restated Directors' Deferred Share Sub-Plan of the KeyCorp 2026 Equity Compensation Plan.
Payment of these Deferred Shares has been deferred until October 1, 2029. Following this award, Gile now holds 132,059 Deferred Shares, including approximately 1,338 dividend-equivalent Deferred Shares accrued in March 2026, and 45,201 Common Shares directly. This is a routine, non-cash equity compensation transaction rather than an open-market trade.
Dallas H James reported acquisition or exercise transactions in this Form 4 filing.
KeyCorp director Dallas H. James reported a routine equity compensation grant. He received 7,352 Deferred Shares on Common Shares-equivalent terms under KeyCorp’s Amended and Restated Directors’ Deferred Share Sub-Plan of the KeyCorp 2026 Equity Compensation Plan.
Each Deferred Share is the economic equivalent of one Common Share. Under the plan, Mr. James will receive payment of these Deferred Shares one-half as Common Shares and one-half in cash on May 14, 2029. After these transactions, he holds 138,769 Common Shares directly and 26,777 Deferred Shares.
Tobin Richard J reported acquisition or exercise transactions in this Form 4 filing.
KeyCorp director Richard J. Tobin received an award of 7,352 Deferred Shares, each economically equivalent to one Common Share. Under the directors' Deferred Share Plan, these will be paid half in Common Shares and half in cash on May 14, 2029. After this award, he holds 84,896 Deferred Shares and 750 Common Shares directly.
VASOS TODD J reported acquisition or exercise transactions in this Form 4 filing.
KeyCorp director Todd J. Vasos reported updated holdings and a new equity award. He received a grant of 7,352 Deferred Shares, each economically equivalent to one Common Share, under KeyCorp's Amended and Restated Directors' Deferred Share Sub-Plan of the KeyCorp 2026 Equity Compensation Plan.
Payment of these Deferred Shares has been deferred until July 1, 2029. Following this award, Vasos directly holds 35,255 Common Shares and 75,450 Deferred Shares, reflecting both his share ownership and deferred equity-based compensation position.
KEYCORP /NEW/ director Antonio DeSpirito III filed an initial Form 3 showing his current equity stake in the company. The filing reports beneficial ownership of 4,450 Common Shares, held directly. This is a baseline disclosure of his holdings, not a report of a new trade.
KeyCorp director Christopher L. Henson has filed an initial statement of ownership on Form 3. The filing reports beneficial ownership of 250 Common Shares held directly. This is a disclosure of his current stake and does not report any recent share purchases or sales.
KeyCorp reported routine annual meeting results and new capital return actions. Shareholders elected fourteen directors, ratified Ernst & Young as auditor for 2026, approved executive compensation, and approved the 2026 Equity Compensation Plan, which allows a broad range of equity awards and raises the annual equity and cash compensation limit for non-employee directors from $500,000 to $750,000.
The board declared a quarterly cash dividend of $0.205 per common share for the second quarter of 2026, along with scheduled dividends on multiple preferred stock series, all payable on June 15, 2026. The board also authorized a new share repurchase program under which KeyCorp may repurchase up to $3.0 billion of common shares, replacing a prior $1.0 billion authorization that had approximately $280 million remaining.
KEYCORP director Richard J. Hipple reported compensation-related transactions involving Deferred Shares and Common Shares. On May 11, 2026, he exercised 18,118 Deferred Shares that were economically equivalent to Common Shares. According to the disclosure, 9,059 Deferred Shares were settled for cash based on a 30‑day average closing price, and the remaining 9,058 Deferred Shares were settled for an equal number of Common Shares. A related disposition entry shows 9,059 Common Shares transferred to the issuer at $21.41 per share, leaving Hipple with 104,575 Common Shares held directly. The position also reflects approximately 4,096 Common Shares from dividend reinvestments and 1,637 dividend‑equivalent Deferred Shares accrued between June 2025 and March 2026.
KeyCorp director Barbara R. Snyder exercised and settled deferred share units and reduced her direct shareholdings through an internal transaction with the company. She exercised derivative rights tied to 18,118 Deferred Shares, receiving an equal number of Common Shares at a stated price of $0.0000 per share.
On the same date, 9,059 of her Deferred Shares were settled for cash based on the average closing price of KeyCorp Common Shares over the prior 30 trading days, while 9,058 Deferred Shares were settled into an equal number of Common Shares. A related disposition to the issuer covered 9,059 Common Shares at $21.41 per share, leaving her with 91,288 Common Shares held directly after these transactions.